Newsmeme!
Discover News you didn't know existed
Teva Pharmaceutical Industries Ltd and its partner, Antares Pharma, Inc announced the approval of a Supplemental New Drug Application (sNDA), which added 'needle-free injection' to its Tev-Tropin [somatropin (rDNA) for injection] brand human growth hormone (hGH) drug label.
Israel stocks poised to end the month of June on a mixed note, with strength in Bezeq and Teva as well as certain technology stocks offset by weakness in the banks and Israel Chemicals.
The firm has been marketing Tev-Tropin since 2005, but only with a regular injection.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |